Product Images Levulan Kerastick

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 15 images provide visual information about the product associated with Levulan Kerastick NDC 67308-101 by Dusa Pharmaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Levulan 01

Levulan 01

Levulan 02

Levulan 02

Levulan 03

Levulan 03

Levulan 04

Levulan 04

Levulan 05

Levulan 05

Levulan 06

Levulan 06

The text provides a graph (Figure 4) showing the percentage of subjects (N=110) who achieved complete response, that is, 100% clearance of treated lesions, over the course of several months.*

Levulan 07

Levulan 07

Levulan 08

Levulan 08

The text describes the enrollment and treatment of 269 individuals using Levulan light and Vehicle/light in weeks 0 and 8. There are not clear results for some patients in week 8, and some patients were retreated in week 12. The number of patients with clear and not clear results is listed for each treatment group and time point.*

Levulan 09

Levulan 09

Levulan 10

Levulan 10

Levulan 11

Levulan 11

The text appears to be a description of a medication called "LEVULAN KERASTICK®". The medication is a topical solution containing 4 (aminolevulinic acid HC). However, the description does not provide any information on what the medication is used for or how to administer it.*

Levulan 12

Levulan 12

Levulan 13

Levulan 13

Levulan 14

Levulan 14

LEVULAN" KERASTICK is a 20% topical solution of aminolevulinic acid HCI for a single user. The rest of the text is not readable.*

Levulan 15

Levulan 15

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.